Unichem Lab gains on receiving USFDA nod for seizure treatment drug

14 Oct 2022 , 11:25 AM

The said drug is a generic version of Dilantin (Phenytoin Sodium) capsules of Viatris Specialty LLC. Extended Phenytoin Sodium capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. The product will be commercialized from Unichems Ghaziabad Plant, the drug maker said. Unichem Laboratories is a pharmaceutical company. It addresses the needs of therapeutic areas like gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives and pain management. The company reported consolidated net loss of Rs 23.37 crore in Q1 FY23 as against net loss of Rs 11.49 crore in Q1 FY22. Net sales rose 3.9% year on year to Rs 309.61 crore in the quarter ended 30 June 2022. Powered by Capital Market – Live News